El Salvador validated by WHO as having eliminated trachoma as a public health problem
The World Health Organization (WHO) has validated El Salvador as having eliminated trachoma as a public health problem. Trachoma is the world's leading infectious cause of blindness. "I congratulate
The World Health Organization (WHO) has validated El Salvador as having eliminated trachoma as a public health problem. Trachoma is the world's leadin
Read Full Story at WHO Health →Why This Matters
El Salvador’s elimination of trachoma as a public health threat marks a critical milestone in global health equity, proving that even the world’s poorest nations can tackle neglected tropical diseases with targeted interventions and political will. The certification underscores a rare but growing trend of infectious disease elimination in Latin America, a region often overshadowed by larger health crises like Zika or dengue.
Background Context
Trachoma thrives in conditions of poverty, poor sanitation, and limited access to clean water—factors that for decades trapped rural communities in a cycle of preventable blindness. El Salvador’s success reflects a decades-long effort, including mass drug administration campaigns and hygiene education, which gained momentum after the 2010s as part of broader NTD elimination strategies supported by PAHO and WHO.
What Happens Next
With elimination certified, El Salvador must now maintain surveillance to prevent re-emergence, a challenge that demands sustained funding and community engagement. The model could inspire neighboring countries to double down on trachoma control, though success will hinge on replicating the country’s integrated approach—combining health systems, vector control, and social determinants.
Bigger Picture
This achievement fits a broader pattern of disease elimination in the Americas, where nations like Mexico and Guatemala have also made strides against trachoma. It contrasts with global setbacks in other NTDs, highlighting how targeted, locally driven strategies can outpace the uneven progress seen in malaria or lymphatic filariasis control.
